A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
- DOI
- 10.1186/s13045-026-01836-0
- Published
- 2026 Jul 30
- Container
- Journal of hematology & oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-026-01836-0,
title = {A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.},
author = {Ramírez-Fernández Á and Bear AS and Kamali E and Bartoszek R and Ho M and Chen GM and Dersh D and Córdoba-Espejo L and Liu J and Deng M and Velasco-Sidro M and Jain A and Noll JH and Hopkins CR and Koucky O and Minehart J and Dimitri AJ and Williams E and Lavorando M and Segura-Tudela A and Scholler J and Barber-Rotenberg J and Jadlowsky JK and Powell DJ and Chew A and Gonzalez VE and Siegel DL and Levine BL and Lotze MT and June CH and Riley JL and Vonderheide RH and Herbst F and Fraietta JA},
year = {2026},
journal = {Journal of hematology \& oncology},
doi = {10.1186/s13045-026-01836-0},
url = {https://doi.org/10.1186/s13045-026-01836-0}
}RIS
TY - JOUR TI - A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection. AU - Ramírez-Fernández Á AU - Bear AS AU - Kamali E AU - Bartoszek R AU - Ho M AU - Chen GM AU - Dersh D AU - Córdoba-Espejo L AU - Liu J AU - Deng M AU - Velasco-Sidro M AU - Jain A AU - Noll JH AU - Hopkins CR AU - Koucky O AU - Minehart J AU - Dimitri AJ AU - Williams E AU - Lavorando M AU - Segura-Tudela A AU - Scholler J AU - Barber-Rotenberg J AU - Jadlowsky JK AU - Powell DJ AU - Chew A AU - Gonzalez VE AU - Siegel DL AU - Levine BL AU - Lotze MT AU - June CH AU - Riley JL AU - Vonderheide RH AU - Herbst F AU - Fraietta JA PY - 2026 JO - Journal of hematology & oncology DO - 10.1186/s13045-026-01836-0 UR - https://doi.org/10.1186/s13045-026-01836-0 ER -
APA
Á, R., AS, B., E, K., R, B., M, H., GM, C., D, D., L, C., J, L., M, D., M, V., A, J., JH, N., CR, H., O, K., J, M., AJ, D., E, W., M, L., A, S., J, S., J, B., JK, J., DJ, P., A, C., VE, G., DL, S., BL, L., MT, L., CH, J., JL, R., RH, V., F, H., & JA, F. (2026). A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-026-01836-0
Source records
- pubmed · retrieved 2026-09-25T23:24:30.425Z